Literature DB >> 20373075

No association between AICDA 7888 C/T polymorphism, Helicobacter pylori seropositivity, and the risk of atrophic gastritis and gastric cancer in Japanese.

Asahi Hishida1, Keitaro Matsuo, Yasuyuki Goto, Yoko Mitsuda, Akio Hiraki, Mariko Naito, Kenji Wakai, Kazuo Tajima, Nobuyuki Hamajima.   

Abstract

BACKGROUND: The aberrant expression of activation-induced cytidine deaminase (AICDA) was reportedly induced in gastric epithelial cells infected with cytotoxin-associated gene A (cagA)-positive Helicobacter pylori, resulting in the accumulation of alterations in the TP53 tumor suppressor gene in gastric cells. We investigated the association of the AICDA 7888 C/T polymorphism with H. pylori infection and the risk of gastric cancer and atrophic gastritis in Japanese subjects.
METHODS: The study subjects were 583 histologically diagnosed gastric cancer patients (cases) and 1637 age- and sex-frequency-matched control outpatients, who visited Aichi Cancer Center Hospital from the years 2001 to 2005. In the controls, serum anti-H. pylori IgG antibody and pepsinogens were measured to evaluate H. pylori infection and atrophic gastritis, respectively. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by a logistic model.
RESULTS: H. pylori seropositivity in the controls was not significantly associated with the AICDA 7888 C/T genotypes. Among the H. pylori seropositive control subjects, the age and sex-adjusted ORs of atrophic gastritis were not statistically significant: 0.84 (95% CI, 0.62-1.13) for C/T, 0.82 (95% CI, 0.56-1.21) for T/T, and 0.83 (95% CI, 0.63-1.11) for C/T+T/T, relative to the C/C genotype. The age- and sex-adjusted ORs of gastric cancer relative to atrophic gastritis were also not statistically significant, at 1.17 (95% CI 0.89-1.54), 1.21 (95% CI, 0.85-1.71), and 1.18 (95% CI, 0.91-1.53), respectively. The OR of gastric cancer cases compared with the whole cohort of control subjects was also not significant.
CONCLUSION: The hypothetical association of the AICDA 7888 C/T polymorphism with the risk of gastric cancer or gastric atrophy was not shown in this study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20373075     DOI: 10.1007/s10120-009-0534-7

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  41 in total

1.  Providing AID to p53 mutagenesis.

Authors:  Shigeo Takaishi; Timothy C Wang
Journal:  Nat Med       Date:  2007-04       Impact factor: 53.440

Review 2.  Helicobacter pylori and gastric cancer.

Authors:  Hidekazu Suzuki; Eisuke Iwasaki; Toshifumi Hibi
Journal:  Gastric Cancer       Date:  2009-06-27       Impact factor: 7.370

3.  Serum pepsinogens as a screening test of extensive chronic gastritis.

Authors:  K Miki; M Ichinose; A Shimizu; S C Huang; H Oka; C Furihata; T Matsushima; K Takahashi
Journal:  Gastroenterol Jpn       Date:  1987-04

4.  Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.

Authors:  Shizuka Sasazuki; Manami Inoue; Motoki Iwasaki; Tetsuya Otani; Seiichiro Yamamoto; Shinobu Ikeda; Tomoyuki Hanaoka; Shoichiro Tsugane
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-07       Impact factor: 4.254

5.  AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching.

Authors:  Michel C Nussenzweig; André Nussenzweig; Simone Petersen; Rafael Casellas; Bernardo Reina-San-Martin; Hua Tang Chen; Michael J Difilippantonio; Patrick C Wilson; Leif Hanitsch; Arkady Celeste; Masamichi Muramatsuk; Duane R Pilch; Christophe Redon; Thomas Ried; William M Bonner; Tasuku Honjo
Journal:  Nature       Date:  2001-12-06       Impact factor: 49.962

6.  Association between diversity in the Src homology 2 domain--containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer.

Authors:  Takeshi Azuma; Shiho Yamazaki; Akiyo Yamakawa; Masahiro Ohtani; Atsushi Muramatsu; Hiroyuki Suto; Yoshiyuki Ito; Manabu Dojo; Yukinao Yamazaki; Masaru Kuriyama; Yoshihide Keida; Hideaki Higashi; Masanori Hatakeyama
Journal:  J Infect Dis       Date:  2004-02-02       Impact factor: 5.226

Review 7.  Helicobacter pylori: present status and future prospects in Japan.

Authors:  Hidekazu Suzuki; Toshifumi Hibi; Barry James Marshall
Journal:  J Gastroenterol       Date:  2007-02-16       Impact factor: 7.527

8.  Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa.

Authors:  Roland Rad; Christian Prinz; Bruno Neu; Mathilde Neuhofer; Marco Zeitner; Petra Voland; Ingrid Becker; Wolfgang Schepp; Markus Gerhard
Journal:  J Infect Dis       Date:  2003-07-03       Impact factor: 5.226

Review 9.  Aberrant AID expression and human cancer development.

Authors:  Hiroyuki Marusawa
Journal:  Int J Biochem Cell Biol       Date:  2008-01-25       Impact factor: 5.085

10.  Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).

Authors:  P Revy; T Muto; Y Levy; F Geissmann; A Plebani; O Sanal; N Catalan; M Forveille; R Dufourcq-Labelouse; A Gennery; I Tezcan; F Ersoy; H Kayserili; A G Ugazio; N Brousse; M Muramatsu; L D Notarangelo; K Kinoshita; T Honjo; A Fischer; A Durandy
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

View more
  1 in total

1.  No associations of Toll-like receptor 2 (TLR2) -196 to -174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese.

Authors:  Asahi Hishida; Keitaro Matsuo; Yasuyuki Goto; Mariko Naito; Kenji Wakai; Kazuo Tajima; Nobuyuki Hamajima
Journal:  Gastric Cancer       Date:  2010-12-03       Impact factor: 7.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.